You are being redirected to another site.
The first part of the Urinary Dysfunction in Movement Disorders: A Practical Interdisciplinary Approach module presents an overview of neural control of micturition, highlighting the structures involved in the storage and voiding phases of bladder. The second part highlights the different symptoms presented by patients with MD and NLUTD, classifying them according to the anatomy of the central nervous system dysfunction. The third part discusses practical principles of diagnosis and management of NLUTD in patients with MD.
Alessandra Fanciulli, MD, PhD - Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
Amit Batla, MBBS, MD, DM, MA, FRCP - UCL Queen Square Institute of Neurology, London, United Kingdom
This MDS Interactive module provides learners with an overview of urinary dysfuction in movement disorders including anatomical information, symptoms, diagnosis, and management.
Upon completion of this activity learners will be able to:
1. Provide an overview of neural control of micturition.2. Recognize the clinical features of neurogenic lower urinary tract dysfunction (NLUTD) in movement disorders (MD).3. Discuss practical diagnostic approach and principles of management of NLUTD in patients with MD.
This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.
METHOD OF PARTICIPATION
Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.
EVALUATION & CLAIMING CREDIT
Participants of this educational program will have the opportunity to claim their CME credits upon completion of the evaluation at the conclusion of the module. Please take time to complete the online evaluations as your input and comments are essential in planning future educational programs. The CME certificate is available immediately following the completion of the module.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.
Alessandra Fanciulli: Author
Speaker: AbbVie, Theravance
Amit Batla: Author
Nothing to Disclose
Petra Schwingenschuh: Reviewer
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.
SATISFACTORY COMPLETION
This module will take approximately one (1) hour to complete. Upon watching the lecture, participants are required to complete the module evaluation.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.
MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
CONTENT VALIDITY STATEMENT
All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.
